Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer
Clinical trial NCT05609903 · COMPLETED
Trial details
- NCT number
- NCT05609903
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-01
- Primary completion
- 2020-08-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.